Kiromic Biopharma is an immuno-oncology, target discovery, and gene editing company developing highly effective and safe tumor-specific cancer engineered immunotherapies to face and defeat multiple cancer types. They are focused on extending the benefits of immunotherapy by leveraging DIAMOND AI (Kiromic Diamond Artificial Intelligence), which is a multi-purpose computational platform that can identify new cancer immunological targets for T-Cells and B-Cells.

Biotechnology

Kiromic Biopharma

Kiromic Biopharma's headquarters in Houston, TX, United States

Diane Duyen Nguyen

Scott Dahlbeck

Sarah Madonna

Brandon Ballard

Brittany Tate

Bennie Sewell

Americo Cicchetti

Franco Locatelli

Sandeep Dhanda

Luca Gattinoni

Ruggero M. De Maria

Michael Catlin

Pam Misajon

Amorette Barber

Martin J. D’Souza

The Scientific Advisory team at Kiromic Biopharma provides expert guidance on scientific and clinical strategies to advance the company's immuno-oncology research and development. They leverage their specialized knowledge to assess and refine the DIAMOND AI platform, ensuring the identification of new cancer immunological targets is both accurate and optimized for therapeutic use.

Scientific Advisory

The Independent Directors at Kiromic Biopharma provide unbiased oversight and guidance to the company's management, ensuring adherence to corporate governance standards and ethical practices. They play a crucial role in strategic decision-making, risk management, and safeguarding shareholder interests, while overseeing the company's commitment to developing advanced immunotherapies and leveraging its DIAMOND AI platform.

Independent Directors

This department is responsible for ensuring that products meet quality standards and regulatory requirements through rigorous testing and validation processes.

Quality Assurance

The Leadership Team at Kiromic Biopharma drives the strategic direction and vision of the company, overseeing the development of innovative cancer therapies. Comprised of industry experts, including the CEO and Chief Medical Officer, the team is responsible for advancing research initiatives, fostering collaborations, and ensuring the integration of DIAMOND AI into the company’s operations to enhance target discovery and therapeutic efficacy in immuno-oncology.

Leadership Team

The Scientific Research and Operations team at Kiromic Biopharma is responsible for driving the discovery and development of innovative cancer immunotherapies. This includes overseeing clinical trials, managing laboratory operations, ensuring good manufacturing practices (GMP), and leveraging AI-driven platforms like DIAMOND AI for identifying new immunological targets. The team also handles technical operations, quality assurance, and immune monitoring to support the therapeutic advancements in immuno-oncology.

Kiromic Biopharma

Org chart

Board & advisors

Teams

Scientific Advisory

Independent Directors

Quality Assurance

Leadership Team

Scientific Research and Operations

Offices

Kiromic Biopharma

Org chart

Board & advisors

Teams

Scientific Advisory

Independent Directors

Quality Assurance

Leadership Team

Scientific Research and Operations

Offices

Related companies